Portuguese Newspaper Expresso highlights today the current challenges in rare diseases diagnosis and research in the context of the construction of an EU-Health network to improve healthcare practices throughout Europe.
The article discusses EU health policies aimed at improving collaborative clinical practices to better diagnose and treat rare diseases and addresses research challenges in this field.
Ana Coroadinha, Head of Cell Line Development and Molecular Virology at iBET, was one of the Portuguese scientists interviewed by Expresso about the challenges linked to rare disease research.
In the article, Ana Coroadinha briefly talks about a collaborative project her team is developing with a British partner to develop a gene therapy approach for Duchenne’s Muscular Atrophy, a rare disease affecting the muscles due to a genetic mutation. The challenges in attracting funding for this type of diseases, which affect a low number of patients, are also discussed.
Read the full piece here and explore our website for more information about our gene therapy research and development of virus-based biopharmaceuticals.